CorMedix, Inc. (CRMD)
8.305
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
8.16
-0.14
(-1.75%)
After-Hours: 20:00
CorMedix Cash from Operations (Quarterly) : 86.06M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 86.06M |
| March 31, 2026 | 42.25M |
| December 31, 2025 | 94.46M |
| September 30, 2025 | 30.86M |
| June 30, 2025 | 29.99M |
| March 31, 2025 | 19.74M |
| December 31, 2024 | -5.614M |
| September 30, 2024 | -13.65M |
| June 30, 2024 | -14.04M |
| March 31, 2024 | -17.31M |
| December 31, 2023 | -10.75M |
| September 30, 2023 | -8.698M |
| June 30, 2023 | -8.572M |
| March 31, 2023 | -10.39M |
| December 31, 2022 | -6.155M |
| September 30, 2022 | -5.995M |
| June 30, 2022 | -5.462M |
| March 31, 2022 | -6.744M |
| December 31, 2021 | -5.869M |
| September 30, 2021 | -5.504M |
| June 30, 2021 | -3.092M |
| March 31, 2021 | -6.691M |
| December 31, 2020 | -5.934M |
| September 30, 2020 | -7.313M |
| June 30, 2020 | -0.7544M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.967M |
| December 31, 2019 | -4.112M |
| September 30, 2019 | -3.964M |
| June 30, 2019 | 0.1645M |
| March 31, 2019 | -7.368M |
| December 31, 2018 | -7.200M |
| September 30, 2018 | -5.111M |
| June 30, 2018 | -4.336M |
| March 31, 2018 | -7.054M |
| December 31, 2017 | -7.277M |
| September 30, 2017 | -6.800M |
| June 30, 2017 | -7.751M |
| March 31, 2017 | -6.759M |
| December 31, 2016 | -6.498M |
| September 30, 2016 | -6.549M |
| June 30, 2016 | -3.768M |
| March 31, 2016 | -5.451M |
| December 31, 2015 | -3.635M |
| September 30, 2015 | -2.905M |
| June 30, 2015 | -3.599M |
| March 31, 2015 | -2.216M |
| December 31, 2014 | -1.574M |
| September 30, 2014 | -1.809M |
| June 30, 2014 | -1.729M |
| March 31, 2014 | -1.429M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Innoviva, Inc. | 51.97M |
| Zevra Therapeutics, Inc. | 17.03M |
| Filana Therapeutics, Inc. | -3.855M |
| Eloxx Pharmaceuticals, Inc. | -4.789M |
| Cannabis Global, Inc. | -0.112M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.561M |
| Cash from Financing (Quarterly) | -6.894M |
| Free Cash Flow | 250.11M |
| Free Cash Flow Per Share (Quarterly) | 0.9245 |
| Free Cash Flow to Equity (Quarterly) | 85.23M |
| Free Cash Flow to Firm (Quarterly) | 85.50M |
| Free Cash Flow Yield | 32.95% |